EDGAR Filing Documents for 0001193125-23-276208

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-23-276208

Filing Date

2023-11-13

Accepted

2023-11-13 17:18:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d535320ds3.htm	S-3	284655
2	EX-4.2	d535320dex42.htm	EX-4.2	31914
3	EX-4.3	d535320dex43.htm	EX-4.3	294150
4	EX-5.1	d535320dex51.htm	EX-5.1	23225
5	EX-23.1	d535320dex231.htm	EX-23.1	1903
6	EX-FILING FEES	d535320dexfilingfees.htm	EX-FILING FEES	58653
7	GRAPHIC	g535320dsp0045.jpg	GRAPHIC	6466
8	GRAPHIC	g535320g95o17.jpg	GRAPHIC	29660
	Complete submission text file	0001193125-23-276208.txt		745606

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275525 | Film No.: 231400097
SIC: 2836 Biological Products, (No Diagnostic Substances)